CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer
Investigator(s):
Edward B Garon, MD, MS;
Organization:
UCLA
NCT Number:
Disease Name:
Non-small cell lung cancer
Disease Category:
Trial Phases:
Phase 1
Trial Status:
Recruiting
Trial Contact:
Edward B Garon, MD, MS